1. Home
  2. EMBC vs GGN Comparison

EMBC vs GGN Comparison

Compare EMBC & GGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • GGN
  • Stock Information
  • Founded
  • EMBC 1924
  • GGN 2005
  • Country
  • EMBC United States
  • GGN United States
  • Employees
  • EMBC N/A
  • GGN N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • GGN Finance/Investors Services
  • Sector
  • EMBC Health Care
  • GGN Finance
  • Exchange
  • EMBC Nasdaq
  • GGN Nasdaq
  • Market Cap
  • EMBC 788.4M
  • GGN 720.5M
  • IPO Year
  • EMBC N/A
  • GGN N/A
  • Fundamental
  • Price
  • EMBC $15.11
  • GGN $4.97
  • Analyst Decision
  • EMBC Buy
  • GGN
  • Analyst Count
  • EMBC 2
  • GGN 0
  • Target Price
  • EMBC $18.50
  • GGN N/A
  • AVG Volume (30 Days)
  • EMBC 507.0K
  • GGN 397.4K
  • Earning Date
  • EMBC 08-08-2025
  • GGN 01-01-0001
  • Dividend Yield
  • EMBC 3.90%
  • GGN 10.26%
  • EPS Growth
  • EMBC 18.26
  • GGN N/A
  • EPS
  • EMBC 1.42
  • GGN N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • GGN N/A
  • Revenue This Year
  • EMBC N/A
  • GGN N/A
  • Revenue Next Year
  • EMBC N/A
  • GGN N/A
  • P/E Ratio
  • EMBC $10.82
  • GGN N/A
  • Revenue Growth
  • EMBC N/A
  • GGN N/A
  • 52 Week Low
  • EMBC $9.20
  • GGN $3.51
  • 52 Week High
  • EMBC $21.48
  • GGN $3.91
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 66.06
  • GGN 80.66
  • Support Level
  • EMBC $14.51
  • GGN $4.43
  • Resistance Level
  • EMBC $15.44
  • GGN $4.49
  • Average True Range (ATR)
  • EMBC 0.50
  • GGN 0.05
  • MACD
  • EMBC -0.04
  • GGN 0.02
  • Stochastic Oscillator
  • EMBC 79.59
  • GGN 95.97

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About GGN GAMCO Global Gold Natural Resources & Income Trust

GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.

Share on Social Networks: